Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|September 30, 2005
Protein Z levels and central retinal vein or artery occlusionMaya Koren-Michowitz, Eva Eting, Naomi Rahimi-Levene, et al.
Leukemia Research|November 11, 2011
Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysisMaya Koren-Michowitz, Aiko Sato-Otsubo, Arnon Nagler, et al.
American Journal of Hypertension|March 31, 2005
The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label studyMaya Koren-Michowitz, Victor Dishy, Ronit Zaidenstein, et al.
Medicine|March 22, 2018
Lower hemoglobin transfusion trigger is associated with higher mortality in patients hospitalized with pneumoniaNaomi Rahimi-Levene, Maya Koren-Michowitz, Ronit Zeidenstein, et al.
American Journal of Hematology|December 24, 2019
Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2 V617F mutated plateletsHagit Hauschner, Melanie Bokstad Horev, Modi Misgav, et al.
British Journal of Haematology|April 18, 2013
SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617FMaya Koren-Michowitz, Sigal Gery, Takayuki Tabayashi, et al.
Annals of Hematology|October 14, 2016
Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician surveyMaya Koren-Michowitz, Noa Lavi, Martin H Ellis, et al.
Leukemia Research|August 27, 2017
Ruxolitinib for the management of myelofibrosis: Results of an international physician surveyMartin H Ellis, Maya Koren-Michowitz, Noa Lavi, et al.
The American Journal of the Medical Sciences|May 11, 2021
Hematological Biomarkers, Mortality, Transfusion and Acute Heart DiseaseNaomi Rahimi-Levene, Yoav Preisler, Maya Koren-Michowitz, et al.
European Journal of Rheumatology|August 9, 2022
Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still's DiseaseOfer Levy, Arie Apel, Hossam Alhdor, et al.
Pageof 7